Plehn-Dujowich participates in AIPLA CLE webinar on emerging biotechnologies

Plehn-Dujowich participates in AIPLA CLE webinar on emerging biotechnologies
Emerging Biotech—the Dawn of a New Age
September 20, 2017
 

Debora Plehn-Dujowich, counsel in the firm’s Life Sciences Practice, participated in this webinar on emerging biotechnologies. Topics covered during the webinar include personalized medicine, 3D printing, nanotechnology, CRISPR, the internet of things, neural networks and the use of artificial intelligence in diagnostics. Debora focused her portion of the presentation on IP and regulatory topics including patent eligible subject matter in the U.S. and abroad, and the USPTO Section 101 patent eligible subject matter examples for life sciences.